Literature DB >> 18668824

Ileostomy and excisional surgery for chronic inflammatory disease of the colon: A survey of one hospital region: Part II The health of ileostomists.

.   

Abstract

To the ileostomist who asks, ;Am I as healthy as the rest of the population', the answer can be a qualified affirmative. There is probably an increased likelihood of his developing calculi in the urinary tract but, apart from this, there is no suggestion of diseases of a general nature to which he is more subject than another individual of comparable age. If the surgery has been undertaken for ulcerative colitis in the absence of malignant change and the patient has survived one postoperative year, then an assurance can be given that life expectancy is little less than that in the general population.

Entities:  

Year:  1971        PMID: 18668824      PMCID: PMC1411860          DOI: 10.1136/gut.12.7.536

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  UROLITHIASIS AS A COMPLICATION OF THE SURGICAL TREATMENT OF ULCERATIVE COLITIS.

Authors:  Z MARATKA; J NEDBAL
Journal:  Gut       Date:  1964-06       Impact factor: 23.059

2.  Uric acid stone formation.

Authors:  A W BADENOCH
Journal:  Br J Urol       Date:  1960-12

3.  Analysis of white bile in a case of cholangiocarcinoma of the hepatic ducts.

Authors:  D B GRIFFITHS; M H HABER; K R REES; J F SMITH
Journal:  J Pathol Bacteriol       Date:  1963-04

4.  Pregnancy after ileostomy for chronic ulcerative colitis.

Authors:  H H SCUDAMORE; A G ROGERS; J A BARGEN; E A BANNER
Journal:  Gastroenterology       Date:  1957-02       Impact factor: 22.682

5.  Ileostomy and excision of the large intestine for ulcerative colitis.

Authors:  D W Daly; B N Brooke
Journal:  Lancet       Date:  1967-07-08       Impact factor: 79.321

6.  Nephrolithiasis in inflammatory bowel disease.

Authors:  E A Gelzayd; R I Breuer; J B Kirsner
Journal:  Am J Dig Dis       Date:  1968-12

7.  The outcome of surgery for ulcerative colitis.

Authors:  D W Daly
Journal:  Ann R Coll Surg Engl       Date:  1968-01       Impact factor: 1.891

8.  Uric acid stone formation following ileostomy.

Authors:  R C Bennett; R P Jepson
Journal:  Aust N Z J Surg       Date:  1966-11

9.  Urolithiasis as a complication of chronic diarrheal disease.

Authors:  M S Grossman; F W Nugent
Journal:  Am J Dig Dis       Date:  1967-05

10.  Liver in ulcerative colitis: obstructive jaundice due to bile duct carcinoma.

Authors:  J G Rankin; A P Skyring; S J Goulston
Journal:  Gut       Date:  1966-10       Impact factor: 23.059

View more
  8 in total

1.  Indications and outcome of reoperation for ileostomy complications in inflammatory bowel disease.

Authors:  R M Weaver; J Alexander-Williams; M R Keighley
Journal:  Int J Colorectal Dis       Date:  1988-03       Impact factor: 2.571

2.  Radiological study of changes in the pelvis in women following proctocolectomy.

Authors:  M Asztély; S Palmblad; M Wikland; L Hultén
Journal:  Int J Colorectal Dis       Date:  1991-05       Impact factor: 2.571

3.  The J ileal pouch-anal anastomosis.

Authors:  B A Taylor; R R Dozois
Journal:  World J Surg       Date:  1987-12       Impact factor: 3.352

4.  The relationship between granulomatous bowel disease and duodenal ulcer.

Authors:  M G Sanders; E M Schimmel
Journal:  Am J Dig Dis       Date:  1972-12

5.  The causes of late mortality in ileostomists.

Authors:  J K Ritchie
Journal:  Proc R Soc Med       Date:  1972-01

6.  Urinary changes in patients following restorative proctocolectomy.

Authors:  K Arai; T Fukushima; A Sugita; H Shimada
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

7.  Proctocolectomy for ulcerative colitis.

Authors:  E C Lee; S C Truelove
Journal:  World J Surg       Date:  1980       Impact factor: 3.352

8.  The first 10 years' experience of restorative proctocolectomy for ulcerative colitis.

Authors:  P Setti-Carraro; J K Ritchie; K H Wilkinson; R J Nicholls; P R Hawley
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.